S. Tosti
About
In The Last Decade
S. Tosti
17 papers receiving 346 citations
Peers
Comparison fields: 5 of 49
- Hematology 241
- Immunology 146
- Oncology 112
- Public Health, Environmental and Occupational Health 72
- Molecular Biology 55
Countries citing papers authored by S. Tosti
This map shows the geographic impact of S. Tosti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Tosti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Tosti more than expected).
Fields of papers citing papers by S. Tosti
This network shows the impact of papers produced by S. Tosti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Tosti. The network helps show where S. Tosti may publish in the future.
Co-authorship network of co-authors of S. Tosti
This figure shows the co-authorship network connecting the top 25 collaborators of S. Tosti. A scholar is included among the top collaborators of S. Tosti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Tosti. S. Tosti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 7 | |
| 3 | 17 | |
| 4 | Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit. | 35 |
| 5 | 26 | |
| 6 | ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young age. | 49 |
| 7 | 3 | |
| 8 | 92 | |
| 9 | 1 | |
| 10 | 8 | |
| 11 | Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings. | 3 |
| 12 | IL-2 for the treatment of acute leukemias. | 7 |
| 13 | Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study. | 28 |
| 14 | Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation. | 27 |
| 15 | IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study. | 6 |
| 16 | 33 | |
| 17 | Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings. | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.